Evidence map›Paper›PMID 41813134›Full record

ArticleJournal of clinical and experimental hematopathology : JCEH2026

Diffuse large B-cell lymphoma complicated by cytokine release syndrome and immune effector cell-associated neurotoxicity on day 355 of epcoritamab therapy: a case report.

Yasunobu Sekiguchi, Kosuke Arai, Shizuka Hamano, Masahisa Kudo, Nobuo Maseki, Yoshie Iizaki, Machiko Kawamura, Kazuhiko Kobayashi, Yu Nishimura, Hiroaki Kanda and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical and experimental hematopathology : JCEH, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Yasunobu SekiguchiDepartment of Hematology, Saitama Cancer Center, Kita-adachi-gun, Saitama, Japan.
Kosuke AraiDepartment of Hematology, Saitama Cancer Center, Kita-adachi-gun, Saitama, Japan.
Shizuka HamanoDepartment of Hematology, Saitama Cancer Center, Kita-adachi-gun, Saitama, Japan.
Masahisa KudoDepartment of Hematology, Saitama Cancer Center, Kita-adachi-gun, Saitama, Japan.
Nobuo MasekiDepartment of Hematology, Saitama Cancer Center, Kita-adachi-gun, Saitama, Japan.
Yoshie IizakiDepartment of Hematology, Saitama Cancer Center, Kita-adachi-gun, Saitama, Japan.
Machiko KawamuraDepartment of Hematology, Saitama Cancer Center, Kita-adachi-gun, Saitama, Japan.
Kazuhiko KobayashiDepartment of Inspection Engineering, Saitama Cancer Center, Kita-adachi-gun, Saitama, Japan.
Yu NishimuraDepartment of Pathology, Saitama Cancer Center, Kita-adachi-gun, Saitama, Japan.
Hiroaki KandaDepartment of Pathology, Saitama Cancer Center, Kita-adachi-gun, Saitama, Japan.
Daisuke TakeiDepartment of pharmacy, Saitama Cancer Center, Kita-adachi-gun, Saitama, Japan.
Tomoya AbeDepartment of pharmacy, Saitama Cancer Center, Kita-adachi-gun, Saitama, Japan.
Makoto HanaiDepartment of pharmacy, Saitama Cancer Center, Kita-adachi-gun, Saitama, Japan.
Sayaka EndoDepartment of pharmacy, Saitama Cancer Center, Kita-adachi-gun, Saitama, Japan.
Toshiaki NakayamaDepartment of pharmacy, Saitama Cancer Center, Kita-adachi-gun, Saitama, Japan.
Yasumasa ShimanoDepartment of Radiation therapy, Saitama Cancer Center, Kita-adachi-gun, Saitama, Japan.
Hirofumi KobayashiDepartment of Hematology, Saitama Cancer Center, Kita-adachi-gun, Saitama, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bispecific antibodiescytokine release syndromeepcoritamabimmune effector cell–associated neurotoxicity syndromelate onset

Identifiers

PMID41813134
PMCPMC13472213

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.